Revisiting the role of the granuloma in tuberculosis

Nature Reviews Immunology

Volumn 12, Issue 5, 2012, Pages 352-366

  Ramakrishnan, Lalita ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 12; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN SERINE THREONINE KINASE; STAT4 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; VIRULENCE FACTOR;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; APOPTOSIS; BIOLOGICAL MONITORING; CD4+ T LYMPHOCYTE; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CROHN DISEASE; CYTOKINE RELEASE; DISEASE ASSOCIATION; EFFECTOR CELL; EXTRACELLULAR MATRIX; GENOTYPE; GRANULOMA; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFECTION SENSITIVITY; INHIBITION KINETICS; INNATE IMMUNITY; MACROPHAGE; MOLECULAR DYNAMICS; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; SARCOIDOSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUBERCULOSIS; WEGENER GRANULOMATOSIS;

ANIMALS; GRANULOMA; HUMANS; IMMUNITY, INNATE; TUBERCULOSIS;

EID: 84860247190     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3211     Document Type: Review

References (169)

1. Boros, D. L. (ed.) Granulomatous Infections and Inflammations: Cellular and Molecular Mechanisms (ASM Press, 2003).
2. Sylvius, F. Opera Medica (A. Wolfgang, 1679).
3. Koch, R. The Aetiology of Tuberculosis (eds Pinner, D. M. & Pinner, M.) (National Tuberculosis Association, 1882).
4. Keers, R. Richard Morton (1637-98) and his Phthisiologia. Thorax 37, 26-31 (1982). (Pubitemid 12192064)
5. Myers, J. Development of knowledge of unity of tuberculosis and of the portals of entry of tubercle bacilli. J. Hist. Med. Allied Sci. 29, 213-228 (1974).
6. Sakula, A. Robert Koch: centenary of the discovery of the tubercle bacillus, 1882. Thorax 37, 246-251 (1982). (Pubitemid 12108474)
7. Adams, D. O. The granulomatous inflammatory response. A review. Am. J. Pathol. 84, 164-192 (1976).
8. Spector, W. G. The granulomatous inflammatory exudate. Int. Rev. Exp. Pathol. 8, 1-55 (1969).
9. Williams, G. T. & Williams, W. J. Granulomatous inflammation-a review. J. Clin. Pathol. 36, 723-733 (1983).
10. Adams, D. O. The structure of mononuclear phagocytes differentiating in vivo. I. Sequential fine and histologic studies of the effect of Bacillus Calmette-Guerin (BCG). Am. J. Pathol. 76, 17-48 (1974).
11. Cohn, Z. A. The structure and function of monocytes and macrophages. Adv. Immunol. 9, 163-214 (1968).
12. Dannenberg, A. M. Jr. Cellular hypersensitivity and cellular immunity in the pathogensis of tuberculosis: specificity, systemic and local nature, and associated macrophage enzymes. Bacteriol. Rev. 32, 85-102 (1968).
13. Bouley, D. M., Ghori, N., Mercer, K. L., Falkow, S. & Ramakrishnan, L. Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas. Infect. Immun. 69, 7820-7831 (2001). (Pubitemid 33086613)
14. Helming, L. & Gordon, S. The molecular basis of macrophage fusion. Immunobiology 212, 785-793 (2007). (Pubitemid 350246267)
15. Russell, D. G., Cardona, P. J., Kim, M. J., Allain, S. & Altare, F. Foamy macrophages and the progression of the human tuberculosis granuloma. Nature Immunol. 10, 943-948 (2009).
16. Trogan, E. et al. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc. Natl Acad. Sci. USA 103, 3781-3786 (2006). (Pubitemid 43376632)
17. Weber, C., Zernecke, A. & Libby, P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nature Rev. Immunol. 8, 802-815 (2008).
18. Peyron, P. et al. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4, e1000204 (2008).
19. Canetti, G. The Tubercle Bacillus in the Pulmonary Lesion of Man: Histobacteriology and its Bearing on the Therapy of Pulmonary Tuberculosis (Springer, 1955).
20. Hunter, R. L. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis 91, 497-509 (2011).
21. Kumar, V., Abbas, A. K. & Fausto, N. Robbins and Cotran Pathological Basis of Disease 7th edn (Elsevier Saunders, 2005).
22. Rich, A. R. The Pathogenesis of Tuberculosis (C. C. Thomas, 1946).
23. Volkman, H. E. et al. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327, 466-469 (2010).
24. Cosma, C. L., Sherman, D. R. & Ramakrishnan, L. The secret lives of the pathogenic mycobacteria. Annu. Rev. Microbiol. 57, 641-676 (2003). (Pubitemid 37392957)
25. Feldman, W. H. & Baggenstoss, A. H. The residual infectivity of the primary complex of tuberculosis. Am. J. Pathol. 14, 473-490 (1938).
26. Opie, E. L. & Aronson, J. D. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch. Pathol. Lab. Med. 4, 1-21 (1927).
27. Lawn, S. D. & Zumla, A. I. Tuberculosis. Lancet 378, 57-72 (2011).
28. Rubin, E. J. The granuloma in tuberculosis-friend or foe? N. Engl. J. Med. 360, 2471-2473 (2009).
29. Bold, T. D. & Ernst, J. D. Who benefits from granulomas, mycobacteria or host? Cell 136, 17-19 (2009).
30. Ulrichs, T. & Kaufmann, S. H. New insights into the function of granulomas in human tuberculosis. J. Pathol. 208, 261-269 (2006). (Pubitemid 43126118)
31. Murphy, K., Travers, P. & Walport, M. Janeway's Immunobiology 7th edn (Garland Science, 2008).
32. Mandell, G. L., Bennett, J. E. & Dolin, R. (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 7th edn (Churchill Livingstone, 2010).
33. Schaff, H. & Zumla, A. (eds) Tuberculosis (Saunders Elsevier, 2009).
34. Longo, D. L. et al. (eds) Harrison's Principles of Internal Medicine (McGraw-Hill, 2012).
35. Rohde, K., Yates, R. M., Purdy, G. E. & Russell, D. G. Mycobacterium tuberculosis and the environment within the phagosome. Immunol. Rev. 219, 37-54 (2007). (Pubitemid 47390002)
36. Flynn, J. L. & Chan, J. Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93-129 (2001). (Pubitemid 32368031)
37. Kaufmann, S. H. Is the development of a new tuberculosis vaccine possible? Nature Med. 6, 955-960 (2000).
38. Lawn, S. D., Butera, S. T. & Shinnick, T. M. Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. Microbes Infect. 4, 635-646 (2002). (Pubitemid 34614552)
39. North, R. J. & Izzo, A. A. Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ. Am. J. Pathol. 142, 1959-1966 (1993). (Pubitemid 24057091)
40. Cooper, A. M. et al. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178, 2243-2247 (1993). (Pubitemid 23344885)
41. Cooper, A. M., Magram, J., Ferrante, J. & Orme, I. M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186, 39-45 (1997). (Pubitemid 27304845)
42. Flynn, J. L. et al. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249-2254 (1993). (Pubitemid 23344886)
43. Fremond, C. M. et al. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 179, 1178-1189 (2007).
44. Fremond, C. M. et al. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest. 114, 1790-1799 (2004). (Pubitemid 40385535)
45. Juffermans, N. P. et al. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J. Infect. Dis. 182, 902-908 (2000).
46. Scanga, C. A. et al. MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect. Immun. 72, 2400-2404 (2004). (Pubitemid 38419959)
47. Sugawara, I., Yamada, H. & Mizuno, S. Relative importance of STAT4 in murine tuberculosis. J. Med. Microbiol. 52, 29-34 (2003). (Pubitemid 36106365)
48. Clay, H., Volkman, H. E. & Ramakrishnan, L. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29, 283-294 (2008).
49. Algood, H. M., Lin, P. L. & Flynn, J. L. Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin. Infect. Dis. 41, S189-S193 (2005). (Pubitemid 41022089)
50. Bean, A. G. et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162, 3504-3511 (1999). (Pubitemid 29313602)
51. Chakravarty, S. D. et al. Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs. Infect. Immun. 76, 916-926 (2008). (Pubitemid 351428050)
52. Flynn, J. L. et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2, 561-572 (1995).
53. Kindler, V., Sappino, A. P., Grau, G. E., Piguet, P. F. & Vassalli, P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56, 731-740 (1989). (Pubitemid 19082507)
54. Roach, D. R. et al. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168, 4620-4627 (2002). (Pubitemid 34441368)
55. Stenger, S. Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann. Rheum. Dis. 64, iv24-iv28 (2005). (Pubitemid 41532012)
56. Dannenberg, A. M. Jr. Immunopathogenesis of pulmonary tuberculosis. Hosp. Pract. 28, 51-58 (1993). (Pubitemid 23029754)
57. Wolf, A. J. et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179, 2509-2519 (2007).
58. Wolf, A. J. et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 205, 105-115 (2008). (Pubitemid 351185719)
59. Ramakrishnan, L. Images in clinical medicine. Mycobacterium marinum infection of the hand. N. Engl. J. Med. 337, 612 (1997). (Pubitemid 27360762)
60. North, R. J. & Jung, Y. J. Immunity to tuberculosis. Annu. Rev. Immunol. 22, 599-623 (2004). (Pubitemid 38680435)
61. Swaim, L. E. et al. Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity. Infect. Immun. 74, 6108-6117 (2006). (Pubitemid 44657389)
62. Andersen, P. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand. J. Immunol. 45, 115-131 (1997). (Pubitemid 27047240)
63. Saunders, B. M. & Cooper, A. M. Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol. Cell Biol. 78, 334-341 (2000). (Pubitemid 30655559)
64. Davis, J. M. & Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37-49 (2009).
65. Volkman, H. E. et al. Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. PLoS Biol. 2, e367 (2004).
66. Davis, J. M. et al. Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17, 693-702 (2002). (Pubitemid 35477789)
67. Castellino, F. et al. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440, 890-895 (2006).
68. Okada, T. et al. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol. 3, e150 (2005).
69. Kahnert, A. et al. Mycobacterium tuberculosis triggers formation of lymphoid structure in murine lungs. J. Infect. Dis. 195, 46-54 (2007). (Pubitemid 44958226)
70. Ulrichs, T. et al. Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J. Pathol. 204, 217-228 (2004). (Pubitemid 39335296)
71. Stoll, S., Delon, J., Brotz, T. M. & Germain, R. N. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 296, 1873-1876 (2002). (Pubitemid 34596274)
72. Egen, J. G. et al. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28, 271-284 (2008).
73. Egen, J. G. et al. Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity 34, 807-819 (2011).
74. Sherman, D. R. et al. Mycobacterium tuberculosis H37Rv:ΔRD1 is more virulent than M. bovis bacille Calmette-Guerin in long-term murine infection. J. Infect. Dis. 190, 123-126 (2004). (Pubitemid 38858412)
75. Cosma, C. L., Humbert, O. & Ramakrishnan, L. Superinfecting mycobacteria home to established tuberculous granulomas. Nature Immunol. 5, 828-835 (2004). (Pubitemid 39172976)
76. Dannenberg, A. M. Jr. Macrophage turnover, division and activation within developing, peak and "healed" tuberculous lesions produced in rabbits by BCG. Tuberculosis 83, 251-260 (2003). (Pubitemid 36995247)
77. Savill, J. & Fadok, V. Corpse clearance defines the meaning of cell death. Nature 407, 784-788 (2000).
78. Taylor, R. C., Cullen, S. P. & Martin, S. J. Apoptosis: controlled demolition at the cellular level. Nature Rev. Mol. Cell Biol. 9, 231-241 (2008). (Pubitemid 351301823)
79. Clay, H. et al. Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish. Cell Host Microbe 2, 29-39 (2007). (Pubitemid 47010243)
80. Ray, J. C., Flynn, J. L. & Kirschner, D. E. Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J. Immunol. 182, 3706-3717 (2009).
81. Lin, P. L. et al. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum. 62, 340-350 (2010).
82. Garcia Vidal, C. et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin. Infect. Dis. 40, 756-759 (2005).
83. Iliopoulos, A., Psathakis, K., Aslanidis, S., Skagias, L. & Sfikakis, P. P. Tuberculosis and granuloma formation in patients receiving anti-TNF therapy. Int. J. Tuberc. Lung Dis. 10, 588-590 (2006). (Pubitemid 43667651)
84. Van den Steen, P. E. et al. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37, 375-536 (2002). (Pubitemid 36071972)
85. Banaiee, N., Kincaid, E. Z., Buchwald, U., Jacobs, W. R. Jr & Ernst, J. D. Potent inhibition of macrophage responses to IFN-γ by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J. Immunol. 176, 3019-3027 (2006).
86. Fortune, S. M. et al. Mycobacterium tuberculosis inhibits macrophage responses to IFN-γ through myeloid differentiation factor 88-dependent and-independent mechanisms. J. Immunol. 172, 6272-6280 (2004). (Pubitemid 38621234)
87. Kincaid, E. Z. & Ernst, J. D. Mycobacterium tuberculosis exerts gene-selective inhibition of transcriptional responses to IFN-γ without inhibiting STAT1 function. J. Immunol. 171, 2042-2049 (2003). (Pubitemid 36966487)
88. Ting, L. M., Kim, A. C., Cattamanchi, A. & Ernst, J. D. Mycobacterium tuberculosis inhibits IFN-γ transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163, 3898-3906 (1999). (Pubitemid 29450917)
89. Stockhammer, O. W., Zakrzewska, A., Hegedus, Z., Spaink, H. P. & Meijer, A. H. Transcriptome profiling and functional analyses of the zebrafish embryonic innate immune response to Salmonella infection. J. Immunol. 182, 5641-5653 (2009).
90. Tobin, D. M. et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140, 717-730 (2010).
91. Taylor, J. L. et al. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect. Immun. 74, 6135-6144 (2006). (Pubitemid 44657392)
92. Park, K. J. et al. Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration 72, 166-175 (2005). (Pubitemid 40591530)
93. Price, N. M. et al. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo. J. Immunol. 166, 4223-4230 (2001). (Pubitemid 32224957)
94. Sheen, P. et al. High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation. Eur. Respir. J. 33, 134-141 (2009).
95. Elkington, P. T. et al. Synergistic up-regulation of epithelial cell matrix metalloproteinase-9 secretion in tuberculosis. Am. J. Respir. Cell Mol. Biol. 37, 431-437 (2007). (Pubitemid 47502718)
96. Adams, K. N. et al. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145, 39-53 (2011).
97. Hernandez-Pando, R. et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 356, 2133-2138 (2000).
98. Balasubramanian, V., Wiegeshaus, E. H., Taylor, B. T. & Smith, D. W. Pathogenesis of tuberculosis: pathway to apical localization. Tuber. Lung Dis. 75, 168-178 (1994). (Pubitemid 24217271)
99. Chackerian, A. A., Alt, J. M., Perera, T. V., Dascher, C. C. & Behar, S. M. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 70, 4501-4509 (2002). (Pubitemid 34790962)
100. Schreiber, H. A. et al. Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J. Clin. Invest. 121, 3902-3913 (2011).
101. Welsh, K. J., Risin, S. A., Actor, J. K. & Hunter, R. L. Immunopathology of postprimary tuberculosis: increased T-regulatory cells and DEC-205-positive foamy macrophages in cavitary lesions. Clin. Dev. Immunol. 2011, 307631 (2011).
102. Akira, M., Sakatani, M. & Ishikawa, H. Transient radiographic progression during initial treatment of pulmonary tuberculosis: CT findings. J. Comput. Assist. Tomogr. 24, 426-431 (2000). (Pubitemid 32203936)
103. Bobrowitz, I. D. Reversible roentgenographic progression in the initial treatment of pulmonary tuberculosis. Am. Rev. Respir. Dis. 121, 735-742 (1980). (Pubitemid 10150588)
104. Cree, I. A., Nurbhai, S., Milne, G. & Beck, J. S. Cell death in granulomata: the role of apoptosis. J. Clin. Pathol. 40, 1314-1319 (1987). (Pubitemid 18015261)
105. Keane, J. et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65, 298-304 (1997). (Pubitemid 27008937)
106. Fayyazi, A. et al. Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis. J. Pathol. 191, 417-425 (2000). (Pubitemid 30649911)
107. Tobin, D. et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148, 434-446 (2012).
108. Chen, M. et al. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 205, 2791-2801 (2008).
109. Behar, S. M. et al. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol. 4, 279-287 (2011).
110. Fratazzi, C., Arbeit, R. D., Carini, C. & Remold, H. G. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158, 4320-4327 (1997). (Pubitemid 127483933)
111. Gan, H. et al. Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nature Immunol. 9, 1189-1197 (2008).
112. Keane, J., Shurtleff, B. & Kornfeld, H. TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-γ independent manner. Tuberculosis 82, 55-61 (2002). (Pubitemid 35155419)
113. Oddo, M. et al. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 160, 5448-5454 (1998). (Pubitemid 28267836)
114. Gao, L. Y. et al. A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol. Microbiol. 53, 1677-1693 (2004).
115. Guinn, K. M. et al. Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 51, 359-370 (2004). (Pubitemid 38142126)
116. Choi, H. H. et al. Endoplasmic reticulum stress response is involved in Mycobacterium tuberculosis protein ESAT-6-mediated apoptosis. FEBS Lett. 584, 2445-2454 (2010).
117. Derrick, S. C. & Morris, S. L. The ESAT6 protein of Mycobacterium tuberculosis induces apoptosis of macrophages by activating caspase expression. Cell. Microbiol. 9, 1547-1555 (2007). (Pubitemid 46774025)
118. Mishra, B. B. et al. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell. Microbiol. 12, 1046-1063 (2010).
119. Molloy, A., Laochumroonvorapong, P. & Kaplan, G. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J. Exp. Med. 180, 1499-1509 (1994).
120. Lammas, D. A. et al. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7, 433-444 (1997). (Pubitemid 27446017)
121. Briken, V. & Miller, J. L. Living on the edge: inhibition of host cell apoptosis by Mycobacterium tuberculosis. Future Microbiol. 3, 415-422 (2008).
122. Hinchey, J. et al. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J. Clin. Invest. 117, 2279-2288 (2007). (Pubitemid 47219573)
123. Jayakumar, D., Jacobs, W. R. Jr & Narayanan, S. Protein kinase E of Mycobacterium tuberculosis has a role in the nitric oxide stress response and apoptosis in a human macrophage model of infection. Cell. Microbiol. 10, 365-374 (2008).
124. Velmurugan, K. et al. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathog. 3, e110 (2007).
125. Miller, J. L., Velmurugan, K., Cowan, M. J. & Briken, V. The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-α-mediated host cell apoptosis. PLoS Pathog. 6, e1000864 (2010).
126. Divangahi, M., Desjardins, D., Nunes-Alves, C., Remold, H. G. & Behar, S. M. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nature Immunol. 11, 751-758 (2010).
127. Divangahi, M. et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nature Immunol. 10, 899-906 (2009).
128. Saunders, B. M., Frank, A. A., Orme, I. M. & Cooper, A. M. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cell. Immunol. 216, 65-72 (2002). (Pubitemid 35193446)
129. Cooper, A. M. Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27, 393-422 (2009).
130. Van Rie, A. et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. New Engl. J. Med. 341, 1174-1179 (1999).
131. Verver, S. et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am. J. Respir. Crit. Care Med. 171, 1430-1435 (2005). (Pubitemid 40800517)
132. Caminero, J. A. et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am. J. Respir. Crit. Care Med. 163, 717-720 (2001). (Pubitemid 32230835)
133. Kaufmann, S. H. How can immunology contribute to the control of tuberculosis? Nature Rev. Immunol. 1, 20-30 (2001). (Pubitemid 33741972)
134. Cosma, C. L., Humbert, O., Sherman, D. R. & Ramakrishnan, L. Trafficking of superinfecting Mycobacterium organisms into established granulomas occurs in mammals and is independent of the Erp and ESX-1 mycobacterial virulence loci. J. Infect. Dis. 198, 1851-1855 (2008).
135. Gallegos, A. M., Pamer, E. G. & Glickman, M. S. Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J. Exp. Med. 205, 2359-2368 (2008).
136. Gill, W. P. et al. A replication clock for Mycobacterium tuberculosis. Nature Med. 15, 211-214 (2009).
137. Shafiani, S., Tucker-Heard, G., Kariyone, A., Takatsu, K. & Urdahl, K. B. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J. Exp. Med. 207, 1409-1420 (2010).
138. Khader, S. A. et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nature Immunol. 8, 369-377 (2007). (Pubitemid 46745412)
139. Scott-Browne, J. P. et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 204, 2159-2169 (2007). (Pubitemid 47360876)
140. Kursar, M. et al. Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol. 178, 2661-2665 (2007). (Pubitemid 46333142)
141. Redford, P. S. et al. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur. J. Immunol. 40, 2200-2210 (2010).
142. Pancholi, P., Mirza, A., Bhardwaj, N. & Steinman, R. M. Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages. Science 260, 984-986 (1993). (Pubitemid 23209972)
143. Bold, T. D., Banaei, N., Wolf, A. J. & Ernst, J. D. Suboptimal activation of antigen-specific CD4+ effector cells enables persistence of M. tuberculosis in vivo. PLoS Pathog. 7, e1002063 (2011).
144. Nagabhushanam, V. et al. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-γ. J. Immunol. 171, 4750-4757 (2003). (Pubitemid 37310593)
145. Beatty, W. L. et al. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1, 235-247 (2000).
146. Desvignes, L. & Ernst, J. D. Interferon-γ-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31, 974-985 (2009).
147. MacMicking, J. D., Taylor, G. A. & McKinney, J. D. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science 302, 654-659 (2003). (Pubitemid 37310923)
148. MacMicking, J. D. et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl Acad. Sci. USA 94, 5243-5248 (1997).
149. Nandi, B. & Behar, S. M. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J. Exp. Med. 208, 2251-2262 (2011).
150. Narui, K. et al. Anti-infectious activity of tryptophan metabolites in the l-tryptophan-l-kynurenine pathway. Biol. Pharm. Bull. 32, 41-44 (2009).
151. Munn, D. H. & Mellor, A. L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 117, 1147-1154 (2007). (Pubitemid 46718399)
152. Schneider, B. E. et al. A role for IL-18 in protective immunity against Mycobacterium tuberculosis. Eur. J. Immunol. 40, 396-405 (2010).
153. Cruz, A. et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J. Exp. Med. 207, 1609-1616 (2010).
154. Dorhoi, A. et al. The adaptor molecule CARD9 is essential for tuberculosis control. J. Exp. Med. 207, 777-792 (2010).
155. Russell, D. G. Who puts the tubercle in tuberculosis? Nature Rev. Microbiol. 5, 39-47 (2007). (Pubitemid 44942302)
156. Brunet, L. R., Finkelman, F. D., Cheever, A. W., Kopf, M. A. & Pearce, E. J. IL-4 protects against TNF-α-mediated cachexia and death during acute schistosomiasis. J. Immunol. 159, 777-785 (1997). (Pubitemid 127484229)
157. Fallon, P. G. & Dunne, D. W. Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection. J. Immunol. 162, 4122-4132 (1999). (Pubitemid 29314797)
158. Fallon, P. G., Richardson, E. J., Smith, P. & Dunne, D. W. Elevated type 1, diminished type 2 cytokines and impaired antibody response are associated with hepatotoxicity and mortalities during Schistosoma mansoni infection of CD4-depleted mice. Eur. J. Immunol. 30, 470-480 (2000). (Pubitemid 30098839)
159. Amiri, P. et al. Tumour necrosis factor α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 356, 604-607 (1992).
160. Bjerkeli, V. et al. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis. Ann. Rheum. Dis. 63, 1659-1663 (2004). (Pubitemid 39573699)
161. Fireman, E., Kraiem, Z., Sade, O., Greif, J. & Fireman, Z. Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases. Clin. Exp. Immunol. 130, 331-337 (2002). (Pubitemid 35286223)
162. Piotrowski, W., Gσrski, P., Pietras, T., Fendler, W. & Szemraj, J. The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis. Med. Sci. Monit. 10, CR598-CR607 (2011).
163. Relman, D. A., Schmidt, T. M., MacDermott, R. P. & Falkow, S. Identification of the uncultured bacillus of Whipple's disease. N. Engl. J. Med. 327, 293-301 (1992).
164. Dolan, M. J. et al. Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann. Intern. Med. 118, 331-336 (1993). (Pubitemid 23070616)
165. Villemin, J. A. Etudes Sur La Tuberculosis (J.-B. Balliere et fils, 1868).
166. Flynn, J. L. Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect. 8, 1179-1188 (2006).
167. Pichugin, A. V., Yan, B. S., Sloutsky, A., Kobzik, L. & Kramnik, I. Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts. Am. J. Pathol. 174, 2190-2201 (2009).
168. Tobin, D. M. & Ramakrishnan, L. Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis. Cell. Microbiol. 10, 1027-1039 (2008). (Pubitemid 351540503)
169. Ramakrishnan, L., Federspiel, N. A. & Falkow, S. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288, 1436-1439 (2000). (Pubitemid 30366332)